565 related articles for article (PubMed ID: 28558814)
41. Recombinant human growth hormone treatment of children on hemodialysis. French Society of Pediatric Nephrology.
Bérard E; Crosnier H; Six-Beneton A; Chevallier T; Cochat P; Broyer M
Pediatr Nephrol; 1998 May; 12(4):304-10. PubMed ID: 9655363
[TBL] [Abstract][Full Text] [Related]
42. Vaccination Practices in Pediatric Dialysis Patients Across Europe. A European Pediatric Dialysis Working Group and European Society for Pediatric Nephrology Dialysis Working Group Study.
Bakkaloğlu SA; Özdemir Atikel Y; Paglialonga F; Stefanidis CJ; Askiti V; Vidal E; Ariceta G; Melek E; Verrina E; Printza N; Vondrak K; Zurowska A; Zagozdzon I; Ekim M; Özmert EN; Dufek S; Jankauskiene A; Schmitt CP; Lévai E; Vande Walle J; Canpolat N; Holtta T; Fischbach M; Klaus G; Aufricht C; Shroff R; Edefonti A
Nephron; 2018; 138(4):280-286. PubMed ID: 29232664
[TBL] [Abstract][Full Text] [Related]
43. Disparity between Nephrologists' Opinions and Contemporary Practices for Community Follow-Up after AKI Hospitalization.
Karsanji DJ; Pannu N; Manns BJ; Hemmelgarn BR; Tan Z; Jindal K; Scott-Douglas N; James MT
Clin J Am Soc Nephrol; 2017 Nov; 12(11):1753-1761. PubMed ID: 29025786
[TBL] [Abstract][Full Text] [Related]
44. European audit of current practice in diagnosis and treatment of childhood growth hormone deficiency.
Juul A; Bernasconi S; Clayton PE; Kiess W; DeMuinck-Keizer Schrama S;
Horm Res; 2002; 58(5):233-41. PubMed ID: 12401943
[TBL] [Abstract][Full Text] [Related]
45. Obesity and nephrology: results of a knowledge and practice pattern survey.
Stenvinkel P; Ikizler TA; Mallamaci F; Zoccali C
Nephrol Dial Transplant; 2013 Nov; 28 Suppl 4():iv99-104. PubMed ID: 23737484
[TBL] [Abstract][Full Text] [Related]
46. Effects of recombinant human growth hormone for 1 year on body composition and muscle strength in children on long-term steroid therapy: randomized controlled, delayed-start study.
Simon D; Alberti C; Alison M; Le Henaff L; Chevenne D; Boizeau P; Canal A; Ollivier G; Decostre V; Jacqz-Aigrain E; Carel JC; Czernichow P; Hogrel JY
J Clin Endocrinol Metab; 2013 Jul; 98(7):2746-54. PubMed ID: 23626006
[TBL] [Abstract][Full Text] [Related]
47. Hormone replacement therapy in children: The use of growth hormone and IGF-I.
Pfäffle R
Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):339-52. PubMed ID: 26051295
[TBL] [Abstract][Full Text] [Related]
48. [Evaluation of growth hormone treatment results in children with chronic renal failure--one center experience].
Szczepańska M; Broll I; Dymon I; Szprynger K
Pol Merkur Lekarski; 2008; 24 Suppl 4():46-50. PubMed ID: 18924502
[TBL] [Abstract][Full Text] [Related]
49. Clinical Characteristics and Long-Term Recombinant Human Growth Hormone Treatment of 18q- Syndrome: A Case Report and Literature Review.
Liu S; Chen M; Yang H; Chen S; Wang L; Duan L; Zhu H; Pan H
Front Endocrinol (Lausanne); 2021; 12():776835. PubMed ID: 34956087
[TBL] [Abstract][Full Text] [Related]
50. Efficacy of Growth Hormone Treatment in Children With Chronic Kidney Disease: Tunisian Experience.
Boussetta A; Laamouri R; Jellouli M; Naija O; Gargah T
Indian Pediatr; 2021 Dec; 58(12):1140-1142. PubMed ID: 34939582
[TBL] [Abstract][Full Text] [Related]
51. Advance care planning in chronic kidney disease: A survey of current practice in Australia.
Luckett T; Spencer L; Morton RL; Pollock CA; Lam L; Silvester W; Sellars M; Detering KM; Butow PN; Tong A; Clayton JM
Nephrology (Carlton); 2017 Feb; 22(2):139-149. PubMed ID: 26860214
[TBL] [Abstract][Full Text] [Related]
52. The impact of short stature on health-related quality of life in children with chronic kidney disease.
Al-Uzri A; Matheson M; Gipson DS; Mendley SR; Hooper SR; Yadin O; Rozansky DJ; Moxey-Mims M; Furth SL; Warady BA; Gerson AC;
J Pediatr; 2013 Sep; 163(3):736-41.e1. PubMed ID: 23628375
[TBL] [Abstract][Full Text] [Related]
53. Long-term results of rhGH treatment in children with renal failure: experience of the French Society of Pediatric Nephrology.
Bérard E; André JL; Guest G; Berthier F; Afanetti M; Cochat P; Broyer M;
Pediatr Nephrol; 2008 Nov; 23(11):2031-8. PubMed ID: 18584215
[TBL] [Abstract][Full Text] [Related]
54. Impact of specialization of primary nephrologist on the care of pediatric hemodialysis patients.
Fadrowski JJ; Frankenfield DL; Friedman AL; Warady BA; Neu AM; Fivush BA
Am J Kidney Dis; 2006 Jan; 47(1):115-21. PubMed ID: 16377392
[TBL] [Abstract][Full Text] [Related]
55. Thyroid function during the first year of recombinant human growth hormone therapy in short stature children.
Căpraru OM; Paşcanu IM
Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):307-14. PubMed ID: 25076692
[TBL] [Abstract][Full Text] [Related]
56. Awareness and implementation in daily practice of the S.E.N.-semFYC consensus document on chronic kidney disease.
Egocheaga MI; Alcázar R; Lobos JM; Górriz JL; Martínez-Castelao A; Pastor A; Martínez I; Caballero F; Sánchez-Celaya M
Nefrologia; 2012; 32(6):797-808. PubMed ID: 23169363
[TBL] [Abstract][Full Text] [Related]
57. Kidney growth and renal functions under the growth hormone replacement therapy in children.
Ece A; Çetinkaya S; Ekşioğlu S; Şenel S; Özkasap S; Giniş T; Sen V; Şahin C
Ren Fail; 2014 May; 36(4):508-13. PubMed ID: 24456095
[TBL] [Abstract][Full Text] [Related]
58. Safety of growth hormone treatment of children with idiopathic short stature: the US experience.
Allen DB
Horm Res Paediatr; 2011; 76 Suppl 3():45-7. PubMed ID: 21912165
[TBL] [Abstract][Full Text] [Related]
59. Growth and nutrition in children with chronic kidney disease.
Chand DH; Vitale VS
Minerva Pediatr; 2010 Jun; 62(3):285-94. PubMed ID: 20467381
[TBL] [Abstract][Full Text] [Related]
60. [Indications for recombinant growth hormone (rhGH) treatment in kidney diseases].
Colombo D; Ghio L; Marchesi F; Giani M; Carcano A; Consalvo G; Edefonti A
Pediatr Med Chir; 1995; 17(1):17-22. PubMed ID: 7739921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
